Skip to main content

CASE REPORT article

Front. Pediatr.
Sec. Pediatric Immunology
Volume 12 - 2024 | doi: 10.3389/fped.2024.1424380
This article is part of the Research Topic Meaningful Cases of Primary Immunodeficiencies, volume IV View all 8 articles

Case report: C3 deficiency in two siblings

Provisionally accepted
Agustín Bernacchia Agustín Bernacchia *Alejandra Ginaca Alejandra Ginaca Sabrina Rotondo Sabrina Rotondo María P. Tejada María P. Tejada Daniela Di Giovanni Daniela Di Giovanni
  • Servicios de Inmunología, Hospital General de Niños Ricardo Gutierrez, Buenos Aires, Argentina

The final, formatted version of the article will be published soon.

    The complement system, a vital component of innate immunity, consists of various proteins and pathways crucial for the recognition and elimination of pathogens. In addition, it plays a major role in the initiation of adaptive response through the opsonization of antigens, contributing to B cell activation and memory maintenance. Deficiencies in complement proteins, particularly C3, can lead to severe and recurrent infections as well as immune complex disorders. Here, we present a case report of two siblings with total C3 deficiency resulting from compound heterozygous mutations in C3 (NM_000064.4): c.305dup; [p.Asn103GlnfsTer66] and c.1269+5G>T, previously unreported in C3-related diseases. Both, the index case and her sister presented a history of recurrent infections since early childhood and one of them developed hemolytic uremic syndrome. Immunological evaluation revealed absent plasma C3 levels, decreased memory B cells, hypogammaglobulinemia, and impaired response to polysaccharide antigens. The siblings showed partial responses to antimicrobial prophylaxis and vaccination, requiring intravenous immunoglobulin replacement therapy, resulting in clinical improvement. Genetic analysis identified additional risk polymorphisms associated with atypical HUS. This case highlights the importance of comprehensive genetic and immunological evaluations in complement deficiencies, along with the potential role of immunoglobulin replacement therapy in managing associated antibody defects.

    Keywords: C3 deficiency, Recurrent infections, Intravenous Immunoglobulin, complement system, Blymphocyte subsets

    Received: 27 Apr 2024; Accepted: 10 Jul 2024.

    Copyright: © 2024 Bernacchia, Ginaca, Rotondo, Tejada and Di Giovanni. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Agustín Bernacchia, Servicios de Inmunología, Hospital General de Niños Ricardo Gutierrez, Buenos Aires, Argentina

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.